Treatment of feline mammary fibroepithelial hyperplasia following a single injection of proligestone

Acta Veterinaria Brno

Volumn 75, Issue 2, 2006, Pages 295-297

  Vitasek R ^a   Dendisova H ^a  

^a UNIVERSITY OF VETERINARY AND PHARMACEUTICAL SCIENCES   (Czech Republic)

Author keywords

Antiprogestin; Progesteron; Progestin; Queen

Indexed keywords

FELIDAE;

EID: 33745884690     PISSN: 00017213     EISSN: 00017213     Source Type: Journal    
DOI: 10.2754/avb200675020295     Document Type: Article

References (15)

1. ALLEN HL 1973: Feline mammary hypertrophy. Vet. Pathol 10: 501-508
2. BLENDINGER K, BOSTEDT H, HOFFMANN B 1994: Induction of abortion and medical-treatment of fibroadenomatosis in a cat using the antigestagen Ru-46534. Kleintierpraxis 39: 495-499
3. ELGER W, CHAWALISZ 1999: Antagonists for gynecological therapy. Reproduktionsmedizin 15: 318-335
4. GORLINGER S, KOOISTRA HS, VAN DEN BROEK A, OKKENS AC 2002: Treatment of fibroadenomatous hyperplasia in cats with aglepristone. J Vet Internal Med 16: 710-713
5. HAYDEN DW, BARNES DM, JOHNSON KH 1989: Morphologic changes in the mammary-gland of megestrol acetate-treated and untreated cats: a retrospective study. Vet Pathol 26: 104-113
6. HOFFMANN B, SCHULER G 2000: Receptor blockers - general aspects with respect to their use in domestic animal reproduction. Anim Reprod Sci 60: 295-312
7. LORETTI AP, IIHA MRS, ORDÁS J, DE LAS MULAS JM 2004: Clinical, pathological and immunohistochemical study of feline mammary fibroepithelial hyperplasia following a single injection of depot medroxyprogesterone acetate. J Feline Med Surg 7: 43-52
8. MACDOUGALL LD 2003: Mammary fibroadenomatous hyperplasia in a young cat attributed to treatment with megestrol acetate. Canad Vet J 44: 227-229
9. MARTÍN DE LAS MULAS J, MILLÁN Y, BAUTISTA MJ, PÉREZ J, CARRASCO L 2000: Oestrogen and progesterone receptors in feline fibroadenomatous change: an immunohistochemical study. Res Vet Sci 68: 15-21
10. MEISL D, HUBLER M, ARNOLD S 2003: Der Progesteronantagonist Aglépristone (Alizine (R)) zur Behandlung der Fibroepithelialen Hyperplasie der Mamma bei der Katze. Schweiz Arch Tierh 145: 130-136
11. MOL JA, VAN GARDEREN E, RUTTEMAN GR, RIJNBERK A 1996: New insights in the molecular mechanism of progestin-induced proliferation of mammary epithelium: Induction of the local biosynthesis of growth hormone (GH) in the mammary gland of dogs, cats and humans. J Steroid Biochem Mol Biol 57: 67-71
12. NAK D, NAK Y, SEYREK-INTAS K, KUMRU IH 2004: Treatment of feline mammary fibroadenomatous hyperplasia with aglepristone. Aust Vet Pract 34: 161-162
13. NIMMO JS, PLUMME, JM 1981: Ultrastructural studies of fibroadenomatous hyperplasia of mammary glands of 2 cats. J Comp Pathol 91: 41-50
14. VAN GARDEREN E, DEWIT M, VOORHOUT WF, RUTTEMAN GR, MOL JA, NEDERBRAGT H, MISDORP W 1997: Expression of growth hormone in canine mammary tissue and mammary tumors - Evidence for a potential autocrine/paracrine stimulatory loop. Amer J Pathol 150: 1037-1047
15. WEHREND A, HOSPES R, GRUBER AD 2001: Treatment of feline mammary fibroadenomatous hyperplasia with a progesterone-antagonist. Vet Rec 148: 346-347